Google
GEHC 株価分析 — GE HEALTHCARE TECHNOLOGIES INC. (Healthcare >> Medical Devices)
GEHC に関するよくある質問
GEHCのPER（株価収益率）は？
GE HEALTHCARE TECHNOLOGIES INC.（GEHC）は現在PER 19.98倍で取引されています。
GEHCのROE（自己資本利益率）は？
GE HEALTHCARE TECHNOLOGIES INC.のROEは14.51%です。
GEHCの配当利回りは？
GE HEALTHCARE TECHNOLOGIES INC.の配当利回りは0.00%です。
GEHCの品質スコア（Quality Score）は？
当社のAIはGEHCの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
GEHCは今が買い時ですか？
当社AIのタイミングスコアは100点中64点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
GEHCはどのセクターに属しますか？
GE HEALTHCARE TECHNOLOGIES INC.はHealthcare >> Medical Devicesセクターに分類されます（NASDAQ市場）
GEHC AI Analysis Summary
Our AI summary for GEHC: GE HEALTHCARE TECHNOLOGIES INC. (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 19.98, ROE of 14.51%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 64/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 68.02
Price
-1.92
(-2.75%)
Day Change
|
|
|---|
GEHC, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 94 |
| Magic Formula Rank by ROA |
1396
|
| Magic Formula Rank by ROE |
1396
|
| Magic Formula Rank by ROIC |
1514
|
| Price | 68.02 |
| PBV / Sector |
2.89 / -101.57
|
| Earning Per Share | 3.40 |
| PE / Sector |
19.98 / 31.23
|
| PEG or PE/Growth / Sector |
2.07 / 0.40
|
| Average 1M Daily Value |
380.77 M
GREAT
|
| Average 1W Daily Value |
564.08 M
|
| Timing Factors |
|
71% |
| Financial Health |
|
43% |
| ポイントになる統計 |
|
58% |
| 配当 |
|
41% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:53 |
| Symbol | GEHC |
| Name | GE HEALTHCARE TECHNOLOGIES INC. |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 454.89 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 31,815.13 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 500 West Monroe Street, Chicago, IL, United States, 60661
Phone: 833 735 1139
Website: https://www.gehealthcare.com
Employees: 54,000
Sector: Healthcare >> Medical Devices
Description: GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
